Research Topics
| R T TsuyukiSummaryAffiliation: University of Alberta Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Long-term impact of a community pharmacist intervention on cholesterol levels in patients at high risk for cardiovascular events: extended follow-up of the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus)Carol Yamada
Pharmacy Department, Grey Nuns Community Health Centre, Edmonton, Alberta, Canada
Pharmacotherapy 25:110-5. 2005..Since most patients were still not at the target LDL level, this finding suggests that continuing intervention is necessary to help patients reach this target...
Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical realityDean T Eurich
School of Public Health, University of Alberta, Edmonton, Alberta, T6G 2G3, Canada
Trials 10:12. 2009..Therefore, we attempted to conduct a pilot study to evaluate the feasibility of undertaking a large randomized controlled trial with clinical endpoints...
The preventing recurrent vascular events and neurological worsening through intensive organized case-management (PREVENTION) trial protocol [clinicaltrials.gov identifier: NCT00931788]Finlay A McAlister
Division of General Internal Medicine, University of Alberta Hospital, 8440 112 Street, Edmonton, Canada
Implement Sci 5:27. 2010..If our intervention improves the provision of secondary prevention therapies in these patients, the clinical (and financial) implications will be enormous...
A cluster randomized trial to assess the impact of opinion leader endorsed evidence summaries on improving quality of prescribing for patients with chronic cardiovascular disease: rationale and design [ISRCTN26365328]Sumit R Majumdar
Department of Medicine, University of Alberta, Edmonton AB and the Institute of Health Economics, Edmonton AB, Canada
BMC Cardiovasc Disord 5:17. 2005..CONCLUSION: If the methods used in this intervention are found to improve prescribing practices, similar interventions could be designed for other chronic conditions dealt with in the outpatient setting...
Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus)Ross T Tsuyuki
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Am J Med 116:130-3. 2004
Contemporary burden of illness of congestive heart failure in CanadaRoss T Tsuyuki
Epidemiology Coordinating and Research, Division of Cardiology, University of Alberta, Edmonton, Canada
Can J Cardiol 19:436-8. 2003..Congestive heart failure (CHF) is associated with high morbidity and mortality; however, there is little contemporary Canadian data to quantify the burden of this illness...
A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)Ross T Tsuyuki
Epidemiology Coordinating and Research EPICORE Centre, Division of Cardiology, University of Alberta, 213 Heritage Medical Research Centre, Edmonton, Alberta, Canada T6G 2S2
Arch Intern Med 162:1149-55. 2002..This study aimed to determine the effect of a program of community pharmacist intervention on the process of cholesterol risk management in patients at high risk for cardiovascular events...
Angiotensin receptor blockers do not increase risk of myocardial infarctionRoss T Tsuyuki
EPICORE Centre, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, 220 College Plaza, University of Alberta Campus, Edmonton, Alberta, Canada T6G 2C8
Circulation 114:855-60. 2006
Acute precipitants of congestive heart failure exacerbationsR T Tsuyuki
Epidemiology Coordinating and Research EPICORE Centre, Division of Cardiology, University of Alberta, 213 Heritage Medical Research Centre, Edmonton, Alberta, Canada T6G 2S2
Arch Intern Med 161:2337-42. 2001..The objective of this study was to prospectively describe the precipitants associated with exacerbation of CHF status in patients enrolled in the Randomized Evaluation of Strategies for Left Ventricular Dysfunction Pilot Study...
Improving hypertension management through pharmacist prescribing; the rural Alberta clinical trial in optimizing hypertension (Rural RxACTION): trial design and methodsTheresa L Charrois
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Implement Sci 6:94. 2011..With Alberta being the first province in Canada to have independent prescribing by pharmacists, it offers a unique opportunity to evaluate outcomes in patients who are prescribed antihypertensive therapy by pharmacists...
Prevalence and treatment patterns of lower extremity peripheral arterial disease among patients at risk in ambulatory health settingsMark Makowsky
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
Can J Cardiol 27:389.e11-8. 2011..Lower extremity peripheral arterial disease (PAD) is underdiagnosed and undertreated in Canada, although data are limited. We sought to measure PAD prevalence and treatment patterns in ambulatory settings...
Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol riskR T Tsuyuki
Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
Ann Pharmacother 33:910-9. 1999..To determine the efficacy of a program of intervention by pharmacists on lipid risk management in patients at high risk for cardiovascular events...
Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacistsS H Simpson
Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
Pharmacotherapy 21:627-35. 2001..The incremental cost to provide the program appeared minimal from both government and pharmacy manager perspectives. It is hoped that these results could support negotiations for reimbursement of clinical pharmacy services with payors...
Impact of opinion leader-endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: a randomized controlled trialSumit R Majumdar
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Am Heart J 153:22.e1-8. 2007....
Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)Scot H Simpson
Institute of Health Economics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
Pharmacotherapy 24:389-94. 2004..Results of this substudy suggest that pharmacists should target this patient group for interventions in cholesterol risk management...
Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in type 2 diabetic patients without established cardiovascular disease: results from a randomized trialN N Ladhani
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada
Diabet Med 29:1433-9. 2012..To determine the impact of adding pharmacists to primary care teams on predicted 10-year risk of cardiovascular events in patients with Type 2 diabetes without established cardiovascular disease...
Improved clinical outcomes associated with metformin in patients with diabetes and heart failureDean T Eurich
Institute of Health Economics, Edmonton, Alberta, Canada
Diabetes Care 28:2345-51. 2005..CONCLUSIONS: Metformin, alone or in combination, in subjects with heart failure and type 2 diabetes was associated with lower morbidity and mortality compared with sulfonylurea monotherapy...
Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosisLauren C Brown
Department of Public Health Sciences, University of Alberta, and the Institute of Health Economics, Edmonton
CMAJ 171:1189-92. 2004..Programs to improve the quality of cardiovascular risk reduction in these high-risk patients are needed...
A multicenter disease management program for hospitalized patients with heart failureRoss T Tsuyuki
Division of Cardiology and Department of Public Health Sciences, Faculty of Medicine and Dentistry, University of Alberta, 220 College Plaza, Edmonton, Canada T6G 2C8
J Card Fail 10:473-80. 2004..030), hospitalization days (812 versus 341, P = .003), and cost of care (2,531 Canadian dollars less per patient) in favor of the PSP. CONCLUSION: Simple interventions can improve ACE inhibitor use and patient outcomes...
Development and validation of a survey to assess barriers to drug use in patients with chronic heart failureScot H Simpson
Institute of Health Economics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
Pharmacotherapy 22:1163-72. 2002..Conclusion. The BMU survey demonstrated reasonable reliability and validity characteristics in this first clinical experience. Despite high adherence, patients still reported barriers that may hinder optimal drug use...
Evaluation of attitudes and perceptions of key clinical stakeholders regarding out-of-hospital diagnosis and treatment of ST elevation myocardial infarction patients using a region-wide surveyN A Rajabali
Epidemiology Coordinating and Research EPICORE Centre, University of Alberta, Edmonton, Alberta, Canada
Emerg Med J 26:371-6. 2009..The purpose of this study was to evaluate perceptions among healthcare stakeholder groups relating to the barriers and facilitators of implementing a PHM programme...
Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trialsP Tandon
Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada
Aliment Pharmacol Ther 25:1017-28. 2007..Although reversal of pretransplant renal dysfunction in hepatorenal syndrome reduces post-transplant complications, the overall impact on morbidity and mortality requires clarification...
Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experienceGlen J Pearson
Department of Medicine, Divisions of Cardiology, Cardiovascular Risk Reduction Clinic, University of Alberta Hospital, Edmonton, Alberta, Canada
Vasc Health Risk Manag 4:1127-35. 2008..We evaluated the impact of a CRRC on lipid levels and assessed the long-term effect of a CRRC in maintaining improved lipid levels following discharge...
Validity and reliability of the Edmonton Frail ScaleDarryl B Rolfson
Division of Geriatric Medicine, University of Alberta, B139C Clin Sci Building, 8440-112 Street, Edmonton, Alberta, Canada, T6G 2B7
Age Ageing 35:526-9. 2006
Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trialScot H Simpson
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Alberta, Canada
Diabetes Care 34:20-6. 2011..To evaluate the effect of adding pharmacists to primary care teams on the management of hypertension and other cardiovascular risk factors in patients with type 2 diabetes...
A meta-analysis of the association between adherence to drug therapy and mortalityScot H Simpson
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada T6G 2N8
BMJ 333:15. 2006..To evaluate the relation between adherence to drug therapy, including placebo, and mortality...
Effects of the 1994 Canadian Cardiovascular Society clinical practice guidelines for congestive heart failureRoss T Tsuyuki
University of Alberta, Edmonton, Canada
Can J Cardiol 18:147-52. 2002..Further efforts to package, deliver and evaluate guidelines are needed...
Patient and informal caregivers' knowledge of heart failure: necessary but insufficient for effective self-careAlexander M Clark
Faculty of Nursing, Level 3 CSB, University of Alberta, Edmonton, AB, Canada T6R 2R6
Eur J Heart Fail 11:617-21. 2009..We aimed to examine the individual and contextual factors perceived by patients and their informal caregivers' to influence their willingness and capacity to undertake effective HF self-care...
The Enhancing Secondary Prevention in Coronary Artery Disease trialFinlay A McAlister
Department of Medicine, University of Alberta, the Royal Alexandra Hospital, Edmonton, Alberta
CMAJ 181:897-904. 2009..We evaluated whether evidence summaries, which were either unsigned or signed by local opinion leaders, improved the quality of secondary prevention care delivered by primary care physicians of patients with coronary artery disease...
Exploring the treatment-risk paradox in coronary diseaseFinlay A McAlister
University of Alberta, Edmonton, Alberta, Canada T6G 2R7
Arch Intern Med 167:1019-25. 2007..The cause of the "treatment-risk paradox" reported for patients with coronary disease is unknown; however, determining the factors that contribute to this paradox is essential to properly design quality improvement interventions...
The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot studyPuneeta Tandon
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Liver Int 29:169-74. 2009....
Community pharmacist-initiated screening program for osteoporosis: randomized controlled trialN Yuksel
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 3126 Dentistry Pharmacy Centre, Edmonton, AB, T6G 2N8, Canada
Osteoporos Int 21:391-8. 2010..Twice as many patients who got the intervention received further testing or treatment for osteoporosis...
Management of hypertension in elderly long-term care residentsRoss T Tsuyuki
Department of Medicine, University of Alberta, Alberta, Canada
Can J Cardiol 24:912-4. 2008..To determine the adequacy of hypertension management in institutionalized elderly patients...
"If he gives in, he will be gone...": the influence of work and place on experiences, reactions and self-care of heart failure in rural CanadaNicole Freydberg
Faculty of Nursing, University of Alberta, Clinical Sciences Building, Edmonton, Alberta, Canada
Soc Sci Med 70:1077-83. 2010..Accounts of HF and its self-care were grounded in work and place-related dimensions of the rural setting. Approaches and interventions related to chronic disease must engage with place and work-related dimensions of context...
Economic implications of treatment guidelines for congestive heart failureMarcelo C Shibata
University of Alberta, Edmonton
Can J Cardiol 21:1301-6. 2005..3 million dollars, giving a net savings of 2.3 million dollars in the first year. The implementation of evidence-based therapy for CHF treatment is not only clinically efficacious, but also economically attractive...
The effects of angiotensin-receptor blockers on mortality and morbidity in heart failure: a systematic reviewM C Shibata
EPICORE Centre, Division of Cardiology, University of Alberta, AB, Canada
Int J Clin Pract 62:1397-402. 2008..Trials evaluating angiotensin-receptor blockers in heart failure (HF) have shown inconsistent results...
Practice-based research: lessons from community pharmacist participantsS H Simpson
EPICORE Center, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
Pharmacotherapy 21:731-9. 2001..Second, it provides needed data to demonstrate the value of enhanced pharmacy practice. Thorough understanding of pharmacists' opinions is necessary to optimize the design of future studies...
Levels of evidence in cardiovascular clinical practice guidelinesM L Ackman
University of Alberta Hospital, Edmonton, Canada
Can J Cardiol 16:1249-54. 2000....
Angiotensin receptor blockers and risk of myocardial infarction: systematic reviewMichael A McDonald
Division of Cardiology, University of Alberta, 2C2 WMC, University of Alberta Hospital, 8440-112 Street, Edmonton, AB, Canada T6G 2B7
BMJ 331:873. 2005..Until further information specifically dealing with this issue is available from large prospective trials, our findings may alleviate recent concerns over the safety of this class of medications...
Reducing costs and improving hypertension managementVida Stankus
EPICORE Centre, Department of Medicine, University of Alberta, Canada
Can J Clin Pharmacol 16:e151-5. 2009..To quantify the cost-savings that could be realized by switching patients from two separate agents, ACE inhibitor/ARB and thiazide diuretic, to a fixed dose combination product...
Patients' achievement of cholesterol targets: a cross-sectional evaluationKari L Olson
Epidemiology Coordinating and Research Centre, Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada T6G 2C8
Am J Prev Med 25:339-42. 2003..This suggests a need for more-aggressive approaches to the management of cholesterol, particularly in high-risk patients...
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic reviewDean T Eurich
Institute of Health Economics, Edmonton, AB, Canada, T5J 3N4
BMJ 335:497. 2007..To review the literature on the association between antidiabetic agents and morbidity and mortality in people with heart failure and diabetes...
Reduced mortality associated with the use of ACE inhibitors in patients with type 2 diabetesDean T Eurich
Institute of Health Economics #1200, 10405 Jasper Ave, Edmonton, Alberta, Canada T5J 3N4
Diabetes Care 27:1330-4. 2004..44-0.90]; P = 0.012). CONCLUSIONS: The use of ACE inhibitors was associated with a significant reduction in all-cause and cardiovascular-related mortality in a broad spectrum of patients with type 2 diabetes and no cardiovascular disease...
Lipid-lowering therapy and outcomes in heart failureJoel G Ray
Department of Medicine, Divisions of General Internal Medicine and Endocrinology and Metabolism, St Michael s Hospital, University of Toronto, 30 Bond Street, Toronto, Ontario, Canada
J Cardiovasc Pharmacol Ther 12:27-35. 2007..More data are needed before statins can be recommended in those with isolated heart failure...
Relation of T-axis abnormalities to coronary artery disease and survival after cardiac catheterizationKannayiram Alagiakrishnan
Division of Geriatric Medicine, University of Alberta, Edmonton, Alberta, Canada
Am J Cardiol 96:639-42. 2005..928). An abnormal T axis was a significant predictor of overall mortality (p = 0.035) for death at any time in our unadjusted survival analysis, and a trend toward poorer survival persisted after adjustment for clinical covariates...
Relationship between number, timing, and type of pharmacist interventions and patient outcomesTheresa L Charrois
Department of Medicine, University of Alberta, Edmonton, Canada
Am J Health Syst Pharm 62:1798-801. 2005
Utilization of evidence-based therapies for heart failure in the institutionalized elderlyMarcelo C Shibata
EPICORE Centre, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Canada
Eur J Heart Fail 7:1122-5. 2005..Efforts to increase the utilization of evidence-based therapies and improve monitoring are warranted...
Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort studyScot H Simpson
Institute of Health Economics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alta
CMAJ 174:169-74. 2006..The same relation was not observed with metformin. This implies that the manner in which blood glucose concentration is lowered may be as important as achieving recommended glucose targets...
Stroke prophylaxis in nonvalvular atrial fibrillationT J Bungard
EPICORE Centre, Division of Cardiology, Cardiology, University of Alberta, Edmonton, Alberta, Canada
Curr Opin Neurol 14:59-65. 2001..Narrowing this gap between research evidence and clinical practice may be accomplished by identifying those patients who are eligible for prophylaxis, and then maintaining them at an adequate level of anticoagulation...
Poor adherence with hypolipidemic drugs: a lost opportunityR T Tsuyuki
Division of Cardiology, University of Alberta, Edmonton, Canada
Pharmacotherapy 21:576-82. 2001..While the search for new, efficacious therapies must continue, efforts focused on improving adherence to proven therapy may have a greater overall impact on health than any single new agent...
A cohort study found the RAND-12 and Health Utilities Index Mark 3 demonstrated construct validity in high-risk primary care patientsDavid Feeny
Institute of Health Economics, 1200, 10405 Jasper Avenue, Edmonton, Alberta, T5J 3N4, Canada
J Clin Epidemiol 58:138-41. 2005..The objective of this study was to examine the construct validity of the RAND-12 and HUI3 in the context of high-risk primary care patients...
Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: the COLLABORATE study [NCT00351676]Mark J Makowsky
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
Med Care 47:642-50. 2009..We sought to determine whether collaborative care including a team-based clinical pharmacist improves the quality of prescribed drug therapy and reduces hospital readmission...
The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomesPuneeta Tandon
Division of General Internal Medicine, University of Alberta, Edmonton, Canada
Arch Intern Med 164:769-74. 2004..In our cohort of elderly patients with multiple comorbidities, beta-blockers were well tolerated...
A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN)Donna L McLean
EPICORE Centre COMPRIS, Division of Cardiology, University of Alberta, 220 College Plaza, Edmonton, AB T6G 2C8, Canada
Arch Intern Med 168:2355-61. 2008..This study aimed to determine the efficacy of a community-based multidisciplinary intervention on BP control in patients with diabetes mellitus...
Development of educational materials for congestive-heart-failure patientsMiriam Fradette
Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
Am J Health Syst Pharm 61:386-9. 2004
Primary health care teams: team members' perceptions of the collaborative processSherry L Dieleman
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
J Interprof Care 18:75-8. 2004
The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillationTammy J Bungard
Division of Cardiology, University of Alberta, Edmonton
Can J Cardiol 19:280-4. 2003..The use of decision support technologies would facilitate involvement of the patient and serve to educate both the patient and physician on the risks and benefits of warfarin therapy...
Pharmacist care of patients with heart failure: a systematic review of randomized trialsSheri L Koshman
Division of Cardiology, Faculty of Medicine and Dentistry, EPICORE Centre COMPRIS, University of Alberta, 220 College Plaza, 8215 112 St NW, Edmonton, Alberta, AB T6G 2C8 Canada
Arch Intern Med 168:687-94. 2008..To clarify the role of pharmacists in the care of patients with HF, we performed a systematic review evaluating the effect of pharmacist care on patient outcomes in HF...
Practice patterns and outcomes in patients presenting to the emergency department with acute heart failureCrystal A Richter
University of Alberta, Edmonton, Canada
Can J Cardiol 25:e173-8. 2009..Heart failure (HF) is a common emergency depart-ment (ED) presentation and a leading reason for hospitalization. Canadian practice patterns for the management of acute HF have not been well described...
Evaluating the views of paramedics, cardiologists, emergency department physicians and nurses on advanced prehospital management of acute ST elevation myocardial infarctionNaheed A Rajabali
Walter C Mackenzie Health Sciences Centre, University of Alberta Hospital, Edmonton, Alberta T6G 2B7, Canada
Can J Cardiol 25:e323-8. 2009..Understanding perceived barriers to and facilitators of PHM implementation may support the expansion of programs, with associated patient benefit...
Management of asthma among community-based primary care physiciansRoss T Tsuyuki
University of Alberta, Edmonton
J Asthma 42:163-7. 2005..CONCLUSIONS: Our study indicates a gap in the provision of asthma education, written action plans, and spirometric testing for patients diagnosed with asthma among primary care physicians...
Underutilisation of ACE inhibitors in patients with congestive heart failureT J Bungard
Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
Drugs 61:2021-33. 2001....
Systematic reviews of pharmacy practice research: methodologic issues in searching, evaluating, interpreting, and disseminating resultsTheresa L Charrois
EPICORE Centre, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Ann Pharmacother 43:118-22. 2009..Well-conducted systematic reviews of pharmacist interventions could go a long way toward changing pharmacy practice and healthcare policy to recognize the important impact that pharmacists could have in the healthcare system...
Stroke prophylaxis in institutionalized elderly patients with atrial fibrillationElaine Lau
Epidemiology Coordinating and Research Centre, Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada
J Am Geriatr Soc 52:428-33. 2004..There is a need for systematic identification of appropriate candidates for anticoagulation in the long-term care setting...
Revascularization in patients with heart failureRoss T Tsuyuki
Division of Cardiology, University of Alberta, Edmonton, Alta
CMAJ 175:361-5. 2006..INTERPRETATION: This new evidence lends support to practice guidelines, which recommend revascularization in patients with heart failure and coronary disease...
Completely autologous platelet gel in breast reduction surgery: a blinded, randomized, controlled trialAlexander Anzarut
Division of Plastic and Reconstructive Surgery and the Department of Surgery, University of Alberta, Edmonton, Alberta, Canada
Plast Reconstr Surg 119:1159-66. 2007..However, there is a paucity of randomized, double-blind, controlled trials assessing the efficacy of these agents...
Collaboration between pharmacists, physicians and nurse practitioners: a qualitative investigation of working relationships in the inpatient medical settingMark J Makowsky
Epidemiology Coordinating and Research EPICORE Centre, University of Alberta, Edmonton, Alberta, Canada
J Interprof Care 23:169-84. 2009..Focussed attention on how practice is structured, team process and ongoing support would enable successful implementation of team-based care in a larger context. (ClinicalTrials.gov number, NCT00351676)...
Improving osteoarthritis detection in the community: pharmacist identification of new, diagnostically confirmed osteoarthritisCarlo A Marra
Collaboration for Outcomes Research and Evaluation, University of British Columbia, Centre for Clinical Epidemiology and Evaluation, British Columbia, Canada
Arthritis Rheum 57:1238-44. 2007..Our objective was to determine if pharmacists, using a simple screening questionnaire, can identify individuals with previously undiagnosed knee OA...
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkersJ Malcom O Arnold
University of Western Ontario, London, Canada
Can J Cardiol 23:21-45. 2007....
Enhancing primary care for complex patients. Demonstration project using multidisciplinary teamsKaren B Farris
College of Pharmacy, University of Iowa, Iowa City 52240, USA
Can Fam Physician 50:998-1003. 2004..Communication between community-based providers is often sporadic and problem-focused...
Patient preferences for ongoing warfarin management after receiving care by an anticoagulation management serviceTammy J Bungard
Am J Health Syst Pharm 65:1498-500. 2008
Recruitment for a provincial asthma study. Participation of network and non-network primary care physiciansDon D Sin
Department of Medicine, University of British Columbia, Vancouver
Can Fam Physician 50:1251-4. 2004
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and managementJ Malcolm O Arnold
University of Western Ontario, London, Canada
Can J Cardiol 22:23-45. 2006..The goal is to translate best evidence-based therapies into clinical practice with a measureable impact on the health of heart failure patients in Canada...
Pharmaceutical care in community pharmacies: practice and research in CanadaErika J M Jones
College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada
Ann Pharmacother 39:1527-33. 2005..CONCLUSIONS: Although Canadian pharmacists' capabilities are not yet universally recognized and applied to their full potential, there is reason to be optimistic about the future of pharmaceutical care in the community setting in Canada...
Transition from unfractionated heparin to low molecular weight heparinsWilliam A Ghali
Thromb Haemost 88:539-40. 2002
Urban and rural differences in the management of asthma amongst primary care physicians in AlbertaElaine Y Lum
University of British Columbia, Canada
Can J Clin Pharmacol 14:e275-82. 2007..Inconsistencies in rural and urban health care exist; however, little has been done to evaluate the potential differences in asthma management...
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathiesJ Malcom
University of Western Ontario, London, Canada
Can J Cardiol 24:21-40. 2008....
Uptake of new treatment strategies for deep vein thrombosis: an international auditDrahomir A Aujesky
University of Lausanne
Int J Qual Health Care 16:193-200. 2004..CONCLUSION: There has been a relatively rapid uptake of LMW heparins and outpatient treatment for DVT in their early years of availability, but the pace of uptake has varied considerably across hospitals and countries...
Cholesterol and osteoporosis in postmenopausal women: a pilot studyKannayiram Alagiakrishnan
J Am Geriatr Soc 51:1510-1. 2003
Effect of a prior authorization process on antiplatelet therapy and outcomes in patients prescribed clopidogrel following coronary stentingMargaret L Ackman
Regional Pharmacy Services, Capital Health
Can J Cardiol 22:1205-8. 2006..CONCLUSIONS: The PA process may have delayed patients filling clopidogrel prescriptions following hospital discharge and has the potential to contribute to negative clinical consequences...
